Herald. Although I disagree with some of Gov. Pillen's decisions, I do agree with him on vouchers for private schools. If all ...
Focus on the code, not the side work.
With Phase 3 data in hand, Intellia Therapeutics is seeking approval for its in vivo CRISPR gene editing therapy for ...